Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What to Expect From Cencora's Next Quarterly Earnings Report

Founded in 1871, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) sources and distributes pharmaceutical products in the United States and internationally. Its U.S. Healthcare Solutions segment serves hospitals, pharmacies, clinics, and specialty providers with drugs, vaccines, plasma products, and related services, alongside data, logistics, and commercialization support. International Healthcare Solutions extends these capabilities overseas, offering pharmaceutical wholesale, global commercialization, and specialized biopharma logistics to healthcare providers worldwide.

The company has a market capitalization of $66 billion and is expected to release its Q1 2026 earnings results on Wednesday, Feb. 4, before the market opens. Ahead of this event, analysts anticipate Cencora to...

Fundamentals

See More
  • Market Capitalization, $K 65,121,512
  • Shares Outstanding, K 193,993
  • Annual Sales, $ 321,333 M
  • Annual Income, $ 1,554 M
  • EBIT $ 4,404 M
  • EBITDA $ 5,472 M
  • 60-Month Beta 0.66
  • Price/Sales 0.20
  • Price/Cash Flow 15.54
  • Price/Book 37.27

Options Overview Details

View History
  • Implied Volatility 26.97% (+1.33%)
  • Historical Volatility 20.83%
  • IV Percentile 76%
  • IV Rank 46.05%
  • IV High 36.68% on 04/08/25
  • IV Low 18.69% on 02/18/25
  • Expected Move (DTE 5) 9.95 (2.96%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 1,081
  • Volume Avg (30-Day) 561
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 31,990
  • Open Int (30-Day) 32,678
  • Expected Range 325.75 to 345.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.04
  • Number of Estimates 6
  • High Estimate 4.39
  • Low Estimate 3.89
  • Prior Year 3.73
  • Growth Rate Est. (year over year) +8.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
329.10 +2.00%
on 01/05/26
351.99 -4.63%
on 12/15/25
-1.60 (-0.47%)
since 12/09/25
3-Month
313.58 +7.05%
on 10/13/25
377.54 -11.08%
on 11/25/25
+21.57 (+6.87%)
since 10/09/25
52-Week
233.61 +43.70%
on 01/13/25
377.54 -11.08%
on 11/25/25
+97.86 (+41.15%)
since 01/08/25

Most Recent Stories

More News
What to Expect From Cencora's Next Quarterly Earnings Report

Cencora is set to report its first-quarter earnings next month, and analysts are anticipating a single-digit increase in its bottom line.

XLV : 157.31 (-0.51%)
$SPX : 6,966.28 (+0.65%)
COR : 335.69 (-0.01%)
3 Healthcare Stocks with Exciting Potential

3 Healthcare Stocks with Exciting Potential

COR : 335.69 (-0.01%)
PODD : 289.04 (-1.31%)
ABBV : 220.08 (-1.81%)
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2026 on Wednesday, February 4, 2026, prior to the opening of trading on the New York Stock...

COR : 335.69 (-0.01%)
2 Large-Cap Stocks Worth Your Attention and 1 We Question

2 Large-Cap Stocks Worth Your Attention and 1 We Question

CVS : 80.30 (-0.37%)
COR : 335.69 (-0.01%)
TEAM : 146.42 (-2.01%)
Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks

Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks

COR : 335.69 (-0.01%)
2 Large-Cap Stocks Worth Investigating and 1 We Find Risky

2 Large-Cap Stocks Worth Investigating and 1 We Find Risky

AMAT : 301.18 (+6.94%)
INTU : 646.90 (-0.90%)
COR : 335.69 (-0.01%)
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

Company reiterates fiscal 2026 guidance Company raises long-term guidance expectations to reflect OneOncology’s expected long-term contribution to enterprise...

COR : 335.69 (-0.01%)
Is Cardinal Health Stock Outperforming the Nasdaq?

Cardinal Health has outperformed the broader Nasdaq index over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.

$NASX : 23,671.35 (+0.81%)
COR : 335.69 (-0.01%)
CAH : 201.11 (-0.68%)
1 S&P 500 Stock to Own for Decades and 2 That Underwhelm

1 S&P 500 Stock to Own for Decades and 2 That Underwhelm

DHI : 157.28 (+7.80%)
COR : 335.69 (-0.01%)
GPC : 128.34 (+1.27%)
Why Cencora (COR) Shares Are Trading Lower Today

Why Cencora (COR) Shares Are Trading Lower Today

COR : 335.69 (-0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 344.52
2nd Resistance Point 342.00
1st Resistance Point 338.84
Last Price 335.69
1st Support Level 333.16
2nd Support Level 330.64
3rd Support Level 327.48

See More

52-Week High 377.54
Last Price 335.69
Fibonacci 61.8% 322.56
Fibonacci 50% 305.58
Fibonacci 38.2% 288.59
52-Week Low 233.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar